We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Princess Private Equity Holding Limited | LSE:PEYS | London | Ordinary Share | GG00B28C2R28 | ORD EUR0.001 (GBP) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
18.00 | 2.00% | 916.00 | 906.00 | 926.00 | 906.00 | 906.00 | 906.00 | 1,124 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 62.21M | 18.42M | 0.2664 | 34.01 | 626.51M |
TIDMPEY TIDMPEYS
RNS Number : 6867I
Princess Private Equity Holding Ltd
28 November 2018
News Release
Guernsey, 28 November 2018
Princess publishes October NAV
-- Princess Private Equity Holding Limited's (Princess) net asset value decreased by 0.6% to EUR 11.37 per share
-- Portfolio developments (-0.6%) were negative and currency movements positive (+0.3%)
-- Princess received distributions of EUR 3.0 million and invested EUR 19.7 million over the month
Princess received distributions of EUR 3.0 million during the month, of which EUR 1.8 million came predominantly from Princess' mature legacy fund portfolio.
Princess invested a total of EUR 19.7 million in October. EUR 19.1 million were provided as debt financing to Envision Healthcare, in support of KKR's privatization of the company. The acquisition of Envision Healthcare was valued at USD 9.9 billion in an all-cash transaction for USD 46 per share. Headquartered in the US, the company offers an array of clinical solutions, including ambulatory surgery services, post-acute care, as well as physician-led services. Split up into five divisions, with the two largest being emergency department and hospitalist services and anesthesiology services, the physician-led business served more than 1'800 clinical departments in healthcare facilities across 45 states as of March 2018. Partners Group was attracted to the debt investment based on Envision Healthcare's strong market position, diversified platform and free cash flow generative profile of the business.
A second interim dividend of EUR 0.28 was declared in October, with a payment date of 14 December 2018. Together with the fist interim dividend for 2018 of EUR 0.28 per share, this translates into a dividend yield of 5.3% on the opening NAV.
Further information is available in the monthly report, which can be accessed via: http://www.princess-privateequity.net/financialreports.
Ends.
About Princess
Princess is an investment holding company founded in 1999 and domiciled in Guernsey. It invests, inter alia, in private equity and private debt investments. Princess is advised in its investment activities by Partners Group, a global private markets investment management firm with EUR 67 billion in investment programs under management in private equity, private debt, private real estate and private infrastructure. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS for the Sterling Quote).
Contacts
Princess Private Equity Holding Limited:
princess@partnersgroup.com
www.princess-privateequity.net
Registered Number: 35241
LEI: 54930038LU8RDPFFVJ57
Investor relations contact
George Crowe
Phone: +44 (0)20 7575 2771
Email: george.crowe@partnersgroup.com
Media relations contact
Jenny Blinch
Phone: +44 207 575 2571
Email: jenny.blinch@partnersgroup.com
www.partnersgroup.com
This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.
This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of Princess' website nor the contents of any website accessible from hyperlinks on Princess' website (or any other website) is incorporated into, or forms part of, this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
STRBRBRTMBATBMP
(END) Dow Jones Newswires
November 28, 2018 02:00 ET (07:00 GMT)
1 Year Princess Private Equity Chart |
1 Month Princess Private Equity Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions